LAS VEGAS, NEVADA, Dec. 11, 2017 -- StereoVision Entertainment, Inc. (OTC PINK: SVSN), a publicly traded Nevada corporation, announced today that their majority owned family entertainment subsidiary Inspirational Vision Media Inc. (IVM) signed a co-production J/V with noted actor, producer and writer Dr. Pavan Grover M.D. to develop IVM’s “Legends of Oz” 9 book series into a live action TV series for presentation to Amazon Studios. (https://studios.amazon.com/)
“We welcome the opportunity to co-produce our Legends of Oz series written by one of the world’s leading children’s book authors, Roger S. Baum, with Pavan Grover,” said IVM’s CEO Steven Previch. “With Amazon, Netflix, etc. spending billions of dollars creating original programming we believe this is the right venue and format for our Legends of Oz series. With this programming we hope to keep alive the iconic story of “The Wizard of Oz” for current and future generations.”
StereoVision Entertainment Inc. http://stereovision.com: Headquartered in Las Vegas, Nevada StereoVision is a publicly traded Nevada corporation (OTC:SVSN) focused on creating, acquiring, and producing multimedia content with its media subsidiaries, the wholly owned 9 time Emmy Award-winning production company REZN8, http://rezn8.com, the majority-owned family entertainment company, Inspirational Vision Media, Inc. http://ivmi.biz, and the majority-owned medical cannabis clinic and industrial hemp Florida C corporation MediCannaVision Inc., dba CannaVision. http://cannavisionclinics.com
Safe Harbor Statement: Except for historical information certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and those statements are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The Company cautions that these forward-looking statements are qualified by other factors. The Company undertakes no obligation to publicly update any statements in this release.
Contact: Steve Previch 305-972-1030 [email protected]


DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Anta Sports Expands Global Footprint With Strategic Puma Stake
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 



